EARly Prevention of aTHeroma Progression
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 111 participants.
Also called NCT02105623
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 111 participants
- Registry
-
NCT02105623
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT02105623. Randomized; no masking; primary purpose treatment. Start 2014-06 (actual); primary completion 2018-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EARly Prevention of aTHeroma Progression
- Acronym
- EARTH
- Condition
- Coronary Arteriosclerosis
- Intervention (Behavioral)
- Standard Therapy
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- CHEOL WHAN LEE, M.D., Ph.D
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct02105623- Content hash
0219cff666eacfa452d812d4645766ce030c3e53f55e1cdc7898e1b7592bea7e